MANITEX INTERNATIONAL INC (MNTX)

US5634201082 - Common Stock

5.8  +0.01 (+0.17%)

Fundamental Rating

3

Overall MNTX gets a fundamental rating of 3 out of 10. We evaluated MNTX against 131 industry peers in the Machinery industry. There are concerns on the financial health of MNTX while its profitability can be described as average. MNTX has a correct valuation and a medium growth rate.



4

1. Profitability

1.1 Basic Checks

MNTX had positive earnings in the past year.
MNTX had a positive operating cash flow in the past year.
MNTX had negative earnings in 4 of the past 5 years.
MNTX had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

MNTX has a Return On Assets of 3.75%. This is comparable to the rest of the industry: MNTX outperforms 51.18% of its industry peers.
MNTX has a better Return On Equity (12.45%) than 64.57% of its industry peers.
With a decent Return On Invested Capital value of 9.67%, MNTX is doing good in the industry, outperforming 66.14% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MNTX is significantly below the industry average of 11.22%.
The last Return On Invested Capital (9.67%) for MNTX is above the 3 year average (3.96%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.75%
ROE 12.45%
ROIC 9.67%
ROA(3y)-0.58%
ROA(5y)-2.79%
ROE(3y)-1.72%
ROE(5y)-7.11%
ROIC(3y)3.96%
ROIC(5y)N/A

1.3 Margins

MNTX has a Profit Margin of 3.19%. This is comparable to the rest of the industry: MNTX outperforms 43.31% of its industry peers.
With a Operating Margin value of 6.85%, MNTX perfoms like the industry average, outperforming 44.09% of the companies in the same industry.
In the last couple of years the Operating Margin of MNTX has grown nicely.
MNTX's Gross Margin of 22.56% is on the low side compared to the rest of the industry. MNTX is outperformed by 68.50% of its industry peers.
MNTX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.85%
PM (TTM) 3.19%
GM 22.56%
OM growth 3YN/A
OM growth 5Y19.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.07%
GM growth 5Y3.32%

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MNTX is destroying value.
MNTX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MNTX has more shares outstanding
Compared to 1 year ago, MNTX has an improved debt to assets ratio.

2.2 Solvency

MNTX has an Altman-Z score of 1.76. This is a bad value and indicates that MNTX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.76, MNTX is doing worse than 73.23% of the companies in the same industry.
MNTX has a debt to FCF ratio of 163.64. This is a negative value and a sign of low solvency as MNTX would need 163.64 years to pay back of all of its debts.
With a Debt to FCF ratio value of 163.64, MNTX is not doing good in the industry: 67.72% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.86 indicates that MNTX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.86, MNTX is not doing good in the industry: 78.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 163.64
Altman-Z 1.76
ROIC/WACC0.97
WACC9.93%

2.3 Liquidity

A Current Ratio of 1.64 indicates that MNTX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.64, MNTX is doing worse than 71.65% of the companies in the same industry.
A Quick Ratio of 0.66 indicates that MNTX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.66, MNTX is doing worse than 87.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.66

4

3. Growth

3.1 Past

MNTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.36%, which is quite impressive.
The Earnings Per Share has been growing by 12.70% on average over the past years. This is quite good.
MNTX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.12%.
The Revenue has been growing slightly by 3.78% on average over the past years.
EPS 1Y (TTM)74.36%
EPS 3YN/A
EPS 5Y12.7%
EPS Q2Q%-35.71%
Revenue 1Y (TTM)1.12%
Revenue growth 3Y20.27%
Revenue growth 5Y3.78%
Sales Q2Q%-6.72%

3.2 Future

MNTX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.61% yearly.
MNTX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.22% yearly.
EPS Next Y-32%
EPS Next 2Y8.31%
EPS Next 3Y13.5%
EPS Next 5Y6.61%
Revenue Next Year6.22%
Revenue Next 2Y9.11%
Revenue Next 3Y6%
Revenue Next 5Y4.22%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.53, which indicates a very decent valuation of MNTX.
92.13% of the companies in the same industry are more expensive than MNTX, based on the Price/Earnings ratio.
MNTX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
Based on the Price/Forward Earnings ratio of 8.24, the valuation of MNTX can be described as reasonable.
Based on the Price/Forward Earnings ratio, MNTX is valued cheaply inside the industry as 96.85% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.69. MNTX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.53
Fwd PE 8.24

4.2 Price Multiples

MNTX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MNTX is cheaper than 91.34% of the companies in the same industry.
MNTX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. MNTX is more expensive than 67.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 219.52
EV/EBITDA 6.49

4.3 Compensation for Growth

A more expensive valuation may be justified as MNTX's earnings are expected to grow with 13.50% in the coming years.
PEG (NY)N/A
PEG (5Y)0.67
EPS Next 2Y8.31%
EPS Next 3Y13.5%

0

5. Dividend

5.1 Amount

No dividends for MNTX!.
Industry RankSector Rank
Dividend Yield N/A

MANITEX INTERNATIONAL INC

NASDAQ:MNTX (12/31/2024, 8:00:00 PM)

5.8

+0.01 (+0.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners56.62%
Inst Owner Change4.11%
Ins Owners6.88%
Ins Owner Change0%
Market Cap118.32M
Analysts43.33
Price Target5.92 (2.07%)
Short Float %0.77%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.86%
Min EPS beat(2)-11.76%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)70.28%
Min EPS beat(4)-11.76%
Max EPS beat(4)177.78%
EPS beat(8)6
Avg EPS beat(8)164.09%
EPS beat(12)8
Avg EPS beat(12)125.09%
EPS beat(16)11
Avg EPS beat(16)116.53%
Revenue beat(2)0
Avg Revenue beat(2)-9.03%
Min Revenue beat(2)-12.44%
Max Revenue beat(2)-5.62%
Revenue beat(4)1
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-12.44%
Max Revenue beat(4)2.81%
Revenue beat(8)4
Avg Revenue beat(8)-1.58%
Revenue beat(12)7
Avg Revenue beat(12)-0.42%
Revenue beat(16)11
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-21.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.53
Fwd PE 8.24
P/S 0.4
P/FCF 219.52
P/OCF 10.52
P/B 1.57
P/tB 4.22
EV/EBITDA 6.49
EPS(TTM)0.68
EY11.72%
EPS(NY)0.7
Fwd EY12.13%
FCF(TTM)0.03
FCFY0.46%
OCF(TTM)0.55
OCFY9.5%
SpS14.45
BVpS3.7
TBVpS1.37
PEG (NY)N/A
PEG (5Y)0.67
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 12.45%
ROCE 12.24%
ROIC 9.67%
ROICexc 9.93%
ROICexgc 14.08%
OM 6.85%
PM (TTM) 3.19%
GM 22.56%
FCFM 0.18%
ROA(3y)-0.58%
ROA(5y)-2.79%
ROE(3y)-1.72%
ROE(5y)-7.11%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)6.52%
ROICexgc(5y)N/A
ROCE(3y)5.01%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y17.66%
ROICexc growth 3YN/A
ROICexc growth 5Y21.73%
OM growth 3YN/A
OM growth 5Y19.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.07%
GM growth 5Y3.32%
F-Score8
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 163.64
Debt/EBITDA 2.07
Cap/Depr 97.54%
Cap/Sales 3.63%
Interest Coverage 2.52
Cash Conversion 36.06%
Profit Quality 5.73%
Current Ratio 1.64
Quick Ratio 0.66
Altman-Z 1.76
F-Score8
WACC9.93%
ROIC/WACC0.97
Cap/Depr(3y)86.89%
Cap/Depr(5y)63.01%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.36%
EPS 3YN/A
EPS 5Y12.7%
EPS Q2Q%-35.71%
EPS Next Y-32%
EPS Next 2Y8.31%
EPS Next 3Y13.5%
EPS Next 5Y6.61%
Revenue 1Y (TTM)1.12%
Revenue growth 3Y20.27%
Revenue growth 5Y3.78%
Sales Q2Q%-6.72%
Revenue Next Year6.22%
Revenue Next 2Y9.11%
Revenue Next 3Y6%
Revenue Next 5Y4.22%
EBIT growth 1Y32.05%
EBIT growth 3YN/A
EBIT growth 5Y23.56%
EBIT Next Year92.73%
EBIT Next 3Y34.02%
EBIT Next 5Y17.3%
FCF growth 1Y102.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y239.65%
OCF growth 3Y-43.04%
OCF growth 5Y17.35%